46 min listen
Danny Motyka - Chemistry, Biosynthetics, and the Promise of Novel Psychedelic Medicines
Danny Motyka - Chemistry, Biosynthetics, and the Promise of Novel Psychedelic Medicines
ratings:
Length:
52 minutes
Released:
Dec 20, 2020
Format:
Podcast episode
Description
With a decades-long commitment to psychedelic advocacy and research, a firsthand knowledge of the life-changing benefits of plant medicine, and his role as CEO of Psygen Labs, Danny Motyka brings a unique perspective to the future of psychedelics. In this episode, he and Paul discuss the differences between the cannabis and psychedelic industries, the role of plant medicines as preventative treatments, and what psychedelic therapy might look like in the near future.
Released:
Dec 20, 2020
Format:
Podcast episode
Titles in the series (100)
Tania de Jong AM - Healing the Planet’s Suffering with Plant Medicines: Tania de Jong AM is a trail-blazing Australian soprano, global speaker, and award-winning social entrepreneur who has developed five businesses and three charities—including Mind Medicine Australia, which supports psychedelic-assisted psychotherapy... by The Psychedelic Podcast